2022
DOI: 10.3390/ijms232314759
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advances in Proteomics-Based Approaches to Studying Age-Related Macular Degeneration: A Systematic Review

Abstract: Age-related macular degeneration (AMD) is a common ocular disease characterized by degeneration of the central area of the retina in the elderly population. Progression and response to treatment are influenced by genetic and non-genetic factors. Proteomics is a powerful tool to study, at the molecular level, the mechanisms underlying the progression of the disease, to identify new therapeutic targets and to establish biomarkers to monitor progression and treatment effectiveness. In this work, we systematically… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 148 publications
(147 reference statements)
0
9
0
Order By: Relevance
“…Recent developments in proteomic research have made it possible to identify a set of proteins differentially posttranslationally modified in diseased retinas ( Garcia-Quintanilla et al, 2022 ; Lam et al, 2022 ; Lee et al, 2022 ; Nattinen et al, 2022 ; Smyczynska et al, 2022 ; Zhou H. et al, 2022 ). However, despite advancements in molecular knowledge regarding the retinal pathobiology of ocular diseases, the question of whether the differential expression of proteins associates with altered activity remains unaddressed.…”
Section: Posttranslational Modifications In the Retinamentioning
confidence: 99%
“…Recent developments in proteomic research have made it possible to identify a set of proteins differentially posttranslationally modified in diseased retinas ( Garcia-Quintanilla et al, 2022 ; Lam et al, 2022 ; Lee et al, 2022 ; Nattinen et al, 2022 ; Smyczynska et al, 2022 ; Zhou H. et al, 2022 ). However, despite advancements in molecular knowledge regarding the retinal pathobiology of ocular diseases, the question of whether the differential expression of proteins associates with altered activity remains unaddressed.…”
Section: Posttranslational Modifications In the Retinamentioning
confidence: 99%
“…Alternative proteomics technologies are also being studied. 5 One of which is the blood-based multiple reaction monitoring-mass spectrometry (MRM-MS) assay where the peptides of plasma proteins can be detected for inspection, discovery and validation of plasma protein biomarkers. 6 We subjected 913 clinical plasma samples to a 7plex MRM-MS assay (Figure 1 and Table S1) that contained three peptides of the corresponding three proteins (IGFBP2, SELE and THBS1) and four CFH variants of two risk alleles (rs800292:p.Val62Ile and rs1061170:p.Tyr402His 1 ).…”
Section: Dear Editormentioning
confidence: 99%
“…We thank Mr. Daniel Lee for English proofing. Hee-Sung Ahn 1,2 Youngju Lee 3 Hyeong Min Kim 4 Shinyeong Ju 1 Seonjeong Lee 1,5 Hyeon-Gyo Jeong 1 Sang Jun Park 4 Kyu Hyung Park 4 Junyeop Lee 6 Joo Yong Lee 6 Se Joon Woo 4 Cheolju Lee 1,3,5…”
Section: A C K N O W L E D G E M E N T Smentioning
confidence: 99%
See 1 more Smart Citation
“…The etiology of AMD is not fully understood, yet it is known to be a multifactorial disease, with strong genetic and environmental risk factors, where chronic oxidative stress, impaired clearance and prolonged inflammation result in pathological choroidal neovascularization [2,3]. A number of proteomic studies on AMD have already been conducted, with sometimes conflicting results, yet there are some patterns in the identified proteins and the metabolic pathways that they are involved in that support our current knowledge of the disease's etiology [4][5][6][7]. In our previous studies, we focused on the tear film proteome, providing interesting findings [8][9][10].…”
Section: Introductionmentioning
confidence: 99%